Literature DB >> 10938134

A calcineurin-NFATc3-dependent pathway regulates skeletal muscle differentiation and slow myosin heavy-chain expression.

U Delling1, J Tureckova, H W Lim, L J De Windt, P Rotwein, J D Molkentin.   

Abstract

The differentiation and maturation of skeletal muscle cells into functional fibers is coordinated largely by inductive signals which act through discrete intracellular signal transduction pathways. Recently, the calcium-activated phosphatase calcineurin (PP2B) and the family of transcription factors known as NFAT have been implicated in the regulation of myocyte hypertrophy and fiber type specificity. Here we present an analysis of the intracellular mechanisms which underlie myocyte differentiation and fiber type specificity due to an insulinlike growth factor 1 (IGF-1)-calcineurin-NFAT signal transduction pathway. We demonstrate that calcineurin enzymatic activity is transiently increased during the initiation of myogenic differentiation in cultured C2C12 cells and that this increase is associated with NFATc3 nuclear translocation. Adenovirus-mediated gene transfer of an activated calcineurin protein (AdCnA) potentiates C2C12 and Sol8 myocyte differentiation, while adenovirus-mediated gene transfer of noncompetitive calcineurin-inhibitory peptides (cain or DeltaAKAP79) attenuates differentiation. AdCnA infection was also sufficient to rescue myocyte differentiation in an IGF-depleted myoblast cell line. Using 10T1/2 cells, we demonstrate that MyoD-directed myogenesis is dramatically enhanced by either calcineurin or NFATc3 cotransfection, while a calcineurin inhibitory peptide (cain) blocks differentiation. Enhanced myogenic differentiation directed by calcineurin, but not NFATc3, preferentially specifies slow myosin heavy-chain expression, while enhanced differentiation through mitogen-activated protein kinase kinase 6 (MKK6) promotes fast myosin heavy-chain expression. These data indicate that a signaling pathway involving IGF-calcineurin-NFATc3 enhances myogenic differentiation whereas calcineurin acts through other factors to promote the slow fiber type program.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10938134      PMCID: PMC86143          DOI: 10.1128/MCB.20.17.6600-6611.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  60 in total

1.  Rabbit slow and fast skeletal muscle-derived satellite myoblast phenotypes do not involve constitutive differences in the components of the insulin-like growth factor system.

Authors:  C Barjot; M Navarro; M L Cotten; V Garandel; H Bernardi; F Bacou; B Barenton
Journal:  J Cell Physiol       Date:  1996-11       Impact factor: 6.384

2.  Insulin-like growth factors require phosphatidylinositol 3-kinase to signal myogenesis: dominant negative p85 expression blocks differentiation of L6E9 muscle cells.

Authors:  P Kaliman; J Canicio; P R Shepherd; C A Beeton; X Testar; M Palacín; A Zorzano
Journal:  Mol Endocrinol       Date:  1998-01

3.  Partial transformation from fast to slow muscle fibers induced by deafferentation of capsaicin-sensitive muscle afferents.

Authors:  O Brunetti; A M Barazzoni; G Della Torre; P Clavenzani; V E Pettorossi; R Bortolami
Journal:  Muscle Nerve       Date:  1997-11       Impact factor: 3.217

Review 4.  Transcription factors of the NFAT family: regulation and function.

Authors:  A Rao; C Luo; P G Hogan
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

Review 5.  Mechanisms of formation of muscle fiber types.

Authors:  F E Stockdale
Journal:  Cell Struct Funct       Date:  1997-02       Impact factor: 2.212

6.  A calcineurin-dependent transcriptional pathway for cardiac hypertrophy.

Authors:  J D Molkentin; J R Lu; C L Antos; B Markham; J Richardson; J Robbins; S R Grant; E N Olson
Journal:  Cell       Date:  1998-04-17       Impact factor: 41.582

7.  Insulin-like growth factor (IGF-I) induces myotube hypertrophy associated with an increase in anaerobic glycolysis in a clonal skeletal-muscle cell model.

Authors:  C Semsarian; P Sutrave; D R Richmond; R M Graham
Journal:  Biochem J       Date:  1999-04-15       Impact factor: 3.857

8.  Altered expression of tropomodulin in cardiomyocytes disrupts the sarcomeric structure of myofibrils.

Authors:  M A Sussman; S Baqué; C S Uhm; M P Daniels; R L Price; D Simpson; L Terracio; L Kedes
Journal:  Circ Res       Date:  1998 Jan 9-23       Impact factor: 17.367

9.  Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF-kappaB activation.

Authors:  S Meyer; N G Kohler; A Joly
Journal:  FEBS Lett       Date:  1997-08-18       Impact factor: 4.124

10.  Differential activation of transcription factors induced by Ca2+ response amplitude and duration.

Authors:  R E Dolmetsch; R S Lewis; C C Goodnow; J I Healy
Journal:  Nature       Date:  1997-04-24       Impact factor: 49.962

View more
  89 in total

1.  Activation of MEF2 by muscle activity is mediated through a calcineurin-dependent pathway.

Authors:  H Wu; B Rothermel; S Kanatous; P Rosenberg; F J Naya; J M Shelton; K A Hutcheson; J M DiMaio; E N Olson; R Bassel-Duby; R S Williams
Journal:  EMBO J       Date:  2001-11-15       Impact factor: 11.598

2.  Regulation of myosin heavy chain expression during rat skeletal muscle development in vitro.

Authors:  C E Torgan; M P Daniels
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

3.  Improved contractile function of the mdx dystrophic mouse diaphragm muscle after insulin-like growth factor-I administration.

Authors:  Paul Gregorevic; David R Plant; Kerri S Leeding; Leon A Bach; Gordon S Lynch
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

4.  p38 Mitogen-activated protein kinase-, calcium-calmodulin-dependent protein kinase-, and calcineurin-mediated signaling pathways transcriptionally regulate myogenin expression.

Authors:  Qing Xu; Lu Yu; Lanying Liu; Ching Fung Cheung; Xue Li; Siu-Pok Yee; Xiang-Jiao Yang; Zhenguo Wu
Journal:  Mol Biol Cell       Date:  2002-06       Impact factor: 4.138

5.  NFAT is a nerve activity sensor in skeletal muscle and controls activity-dependent myosin switching.

Authors:  Karl J A McCullagh; Elisa Calabria; Giorgia Pallafacchina; Stefano Ciciliot; Antonio L Serrano; Carla Argentini; John M Kalhovde; Terje Lømo; Stefano Schiaffino
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-09       Impact factor: 11.205

6.  Six1 and Eya1 expression can reprogram adult muscle from the slow-twitch phenotype into the fast-twitch phenotype.

Authors:  Raphaelle Grifone; Christine Laclef; François Spitz; Soledad Lopez; Josiane Demignon; Jacques-Emmanuel Guidotti; Kiyoshi Kawakami; Pin-Xian Xu; Robert Kelly; Basil J Petrof; Dominique Daegelen; Jean-Paul Concordet; Pascal Maire
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

7.  Mitochondrial fission is required for cardiomyocyte hypertrophy mediated by a Ca2+-calcineurin signaling pathway.

Authors:  Christian Pennanen; Valentina Parra; Camila López-Crisosto; Pablo E Morales; Andrea Del Campo; Tomás Gutierrez; Pablo Rivera-Mejías; Jovan Kuzmicic; Mario Chiong; Antonio Zorzano; Beverly A Rothermel; Sergio Lavandero
Journal:  J Cell Sci       Date:  2014-04-28       Impact factor: 5.285

8.  Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex.

Authors:  Hui-Hua Li; Vishram Kedar; Chunlian Zhang; Holly McDonough; Ranjana Arya; Da-Zhi Wang; Cam Patterson
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

Review 9.  Transcriptional regulation of tumour necrosis factor-related apoptosis-inducing ligand.

Authors:  Nor Saadah M Azahri; Mary M Kavurma
Journal:  Cell Mol Life Sci       Date:  2013-01-18       Impact factor: 9.261

10.  Calcineurin controls nerve activity-dependent specification of slow skeletal muscle fibers but not muscle growth.

Authors:  A L Serrano; M Murgia; G Pallafacchina; E Calabria; P Coniglio; T Lømo; S Schiaffino
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.